Ignite Creation Date:
2024-05-06 @ 2:03 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01968733
Status:
COMPLETED
Last Update Posted:
2017-03-03
First Post:
2013-10-21
Brief Title:
Efficacy and Safety Study of Intravenous to Oral Solithromycin CEM-101 Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Sponsor:
Melinta Therapeutics Inc
Organization:
Melinta Therapeutics Inc
Organization Data
Organization:
Melinta Therapeutics Inc
Class:
INDUSTRY
Study ID:
CE01-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Melinta Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None